Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | NOS3 | P29474 | 3/20 | 0.53 |
| ▸ | NOS1 | P29475 | 3/20 | 0.53 |
| ▸ | NOS2 | P35228 | 3/20 | 0.53 |
| ▸ | DPP4 | P27487 | 3/20 | 0.51 |
| ▸ | FAP | Q12884 | 2/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.51 |
| ▸ | POLQ | O75417 | 1/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MPO | P05164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503201 | 1.00 | PPARG (0.53) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL42975 | 1.00 | PPARG (0.53) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL29410813 | 1.00 | PPARG (0.53) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL19143671 | 0.87 | NOS3 (0.50) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL14489706 | 0.87 | NOS3 (0.52) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL20038753 | 0.87 | NOS3 (0.52) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL5328323 | 0.86 | NOS3 (0.46) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL16938502 | 0.85 | DPP4 (0.50) | PPARGPPARADPP4FAPDPP8 | |
| SCHEMBL9492298 | 0.84 | PPARG (0.57) | PPARGPPARADPP4POLQDPP7 | |
| SCHEMBL26966057 | 0.84 | POLQ (0.48) | PPARGPPARAALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1776 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390784-A | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2025-02-07 | — | — | CN | claimed |
| CN-118440155-B | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2024-11-22 | — | — | CN | claimed |
| CN-114457049-B | Pyrrolysiyl-tRNA synthetase mutant and application thereof | 浙江大学杭州国际科创中心 | 2024-09-24 | — | — | CN | claimed |
| CN-118440155-A | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2024-08-06 | — | — | CN | claimed |
| EP-4401555-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2024-07-24 | — | — | EP | claimed |
| EP-3578566-B1 | BIOCIDAL PEPTIDE AND PREPARATION BASED THEREON | VERTA RES PRODUCTION COMPANY LTD (RU) | 2023-07-19 | — | — | EP | claimed |
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | claimed |
| CN-114457049-A | Pyrrolysinyl-tRNA synthetase mutant and application thereof | 浙江大学杭州国际科创中心 | 2022-05-10 | — | — | CN | claimed |
| US-11059860-B2 | Biocidal peptide and preparation based thereon | VERTA RESEARCH-PRODUCTION COMPANY LTD (RU) | 2021-07-13 | — | — | US | claimed |
| EP-3464324-B1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING BV (NL) | 2021-04-07 | — | — | EP | claimed |
| US-7576175-B2 | Amino acid terminated diphenylurea derivatives; display high binding affinity, specificity, and stability; use in treating cancer, inflammatory diseases, and autoimmune diseases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-08-18 | — | — | US | claimed |
| EP-2036918-A1 | PEPTIDE DERIVATIVE | Vexon, Inc. (JP) | 2009-03-18 | — | — | EP | claimed |
| WO-2008031016-A2 | HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-13 | — | — | WO | claimed |
| US-20080009448-A1 | Peptide Derivative | VEXON, INC. (50%) (JP) | 2008-01-10 | — | — | US | claimed |
| US-7176185-B2 | Short peptide carrier system for cellular delivery of agent | TSRL, INC. (US) | 2007-02-13 | — | — | US | claimed |
| WO-2005122379-A9 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | UNIV CALIFORNIA (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-20050208140-A1 | Short peptide carrier system for cellular delivery of agent | TSRL, INC. | 2005-09-22 | — | — | US | claimed |
| EP-0272694-A1 | 2-Dithioalkyl-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1988-06-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208140-A1 | Short peptide carrier system for cellular delivery of agent | SLC43A1, DNPEP, LNPEP | PPARG 4253/4885PPARA 2972/4885ALPI 2515/4885 |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | PPARG 2322/4885PPARA 1663/4885ALPI 3006/4885 |
| US-20080009448-A1 | Peptide Derivative | ARGLU1, NGLY1, NPR3 | PPARG 4811/4885PPARA 4517/4885ALPI 4171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.